Clinical Trial Detail

NCT ID NCT02498665
Title A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

pancreatic cancer

renal cell carcinoma

lung non-small cell carcinoma

melanoma

ovarian cancer

sarcoma

glioblastoma multiforme

myelodysplastic syndrome

acute myeloid leukemia

Therapies

DSP-7888

Age Groups: adult

No variant requirements are available.